Theranostic applications of an ultra-sensitive t1 and t2 magnetic resonance contrast agent based on cobalt ferrite spinel nanoparticles

HIGHLIGHTS

• who: Georgy Mikhaylov and colleagues from the Department of Biochemistry and Molecular and Structural Biology, Jozef Stefan Institute, Institute of Strength Physics and Materials Science, Tomsk, Russia have published the research work: Theranostic Applications of an Ultra-Sensitive T1 and T2 Magnetic Resonance Contrast Agent Based on Cobalt Ferrite Spinel Nanoparticles, in the Journal: Cancers 2022, 4026 of /2022/
• what: Using (MCFS) nanoparticles this study was aimed at developing a multifunctional drug delivery platform with MRI capability for use in cancer treatment.
• how: To evaluate the efficacy of MCFS nanoparticles as T1 and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.